Great Southern Bancorp, Inc. announces quarterly dividend of $0.40 per common share
SPRINGFIELD, Mo., Dec. 20, 2023 (GLOBE NEWSWIRE) — The Board of Directors of Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding […]
Gray Promotes Bruce Austin to General Manager of WVLT and WBXX in Knoxville, Tennessee
ATLANTA, Dec. 20, 2023 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray”) (NYSE: GTN) today announced its appointment of Bruce Austin […]
TSX News -
Infinico Discovers Lithium Mineralization on Dalhousie Property Under Option from Globex
ROUYN-NORANDA, Quebec, Dec. 20, 2023 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, […]
Rio2 Secures Environmental Approval for Fenix Gold Project
VANCOUVER, British Columbia, Dec. 20, 2023 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: […]
Richardson Electronics, Ltd. and Integrated Power Services (IPS) Announce Partnership to Bring Patented ULTRA3000® to Key Wind Owner Operators
LAFOX, Ill., Dec. 20, 2023 (GLOBE NEWSWIRE) — Richardson Electronics, Ltd. (NASDAQ: RELL), a global provider of engineered solutions for […]
Award of Stock Options
TORONTO, ONTARIO, Dec. 20, 2023 (GLOBE NEWSWIRE) — (“Amaroq” or the “Company”) Award of Stock Options TORONTO, ONTARIO – December […]
WalkMe Survey Shows Half of Workers Don’t File Expense Reports, Leaving Billions of Dollars on the Table
SAN FRANCISCO, Dec. 20, 2023 (GLOBE NEWSWIRE) — WalkMe Inc. (NASDAQ: WKME), a leading provider of digital adoption solutions, today […]
Verizon Frontline Crisis Response Team deployed nearly 800 times in 2023
BASKING RIDGE, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) — First responders across the nation dealt with everything from derechos to […]
Tonix Pharmaceuticals Announces Registered Direct Offering of up to $144 Million
Led by healthcare-focused institutional investors. $30 million financing upfront with up to an additional $114 million tied to the exercise of warrants. CHATHAM, […]
Tonix Pharmaceuticals Announces Highly Statistically Significant and Clinically Meaningful Topline Results in Second Positive Phase 3 Clinical Trial of TNX-102 SL for the Management of Fibromyalgia
Phase 3 RESILIENT study of TNX-102 SL successfully demonstrated daily pain reduction over placebo (primary endpoint, p = 0.00005) All […]
